Advanced Oncotherapy PLC (LON:AVO) insider Enrico Cipro Vanni acquired 40,000 shares of the stock in a transaction on Thursday, January 11th. The stock was acquired at an average cost of GBX 55 ($0.75) per share, for a total transaction of £22,000 ($29,834.55).

Shares of Advanced Oncotherapy PLC (LON AVO) opened at GBX 54.50 ($0.74) on Friday. Advanced Oncotherapy PLC has a twelve month low of GBX 9.75 ($0.13) and a twelve month high of GBX 87 ($1.18). The firm has a market capitalization of $127.30 and a P/E ratio of -340.63.

ILLEGAL ACTIVITY NOTICE: This piece of content was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/14/advanced-oncotherapy-plc-avo-insider-enrico-cipro-vanni-purchases-40000-shares.html.

Advanced Oncotherapy Company Profile

Advanced Oncotherapy Plc is focused on providing radiotherapy systems for cancer treatment through the use of a proton therapy technology. The Company is engaged in development and then building of the Linac Image Guided Hadron Technology (LIGHT) proton beam cancer therapy device and management of healthcare related property.

Insider Buying and Selling by Quarter for Advanced Oncotherapy (LON:AVO)

Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.